The research came first. The capsule is the conclusion.
Allay didn't start with a product idea. It started with homework: reading the forums where GLP-1 users compare notes at 2am, and the clinical studies on what actually runs short during treatment. This page is that story, told straight.
Ten million people, mostly on their own
GLP-1 medication works. That part was never the problem. The problem is everything around it: the queasy weeks after a dose increase, the digestion that slows to a crawl, the hair in the shower drain around month four, the half-finished plates that quietly mean half the vitamins.
And when people go looking for help with that part, they mostly don't find it at the doctor's office. Appointments are short. Leaflets don't cover week one. So users teach each other, in forum threads and comment sections, trading tips with strangers.
Every number on this page is counted or sourced. See the research library for where each one comes from.
So we did the homework
Before Allay was a brand, it was months of reading. Patient reviews, community boards, and the studies on nutrient status during GLP-1 treatment.
People are already building their own stack
The brands that showed up earned the distrust
What's missing is one party that actually did the reading
What we built with it
The research library
The Shot Day Playbook
Allay: 2 clear capsules a day
If the free layers aren't genuinely useful on their own, we haven't earned the right to sell you the third.
The name is the promise
Living on a GLP-1 comes with enough friction already. The point is to remove some of it, not add more.